Discover and read the best of Twitter Threads about #IITIndore
Most recents (1)
The Indian Institute of Technology (IIT) Indore has developed a cost-effective new asparaginase drug with lesser side-effects to treat Acute Lymphoblastic Leukemia (ALL). Asparaginase is an enzyme that is used as a medication, using the protein engineering approach. 
ALL is a type of blood cancer representing nearly a quarter of cancer cases diagnosed among children. Around 25,000, new cases of ALL are diagnosed every year in India.
The institute said that repeated administration of asparaginase, currently to treat ALL, causes serious side-effects such as allergic reactions, neurotoxicity, among others.
